The vaginal pessary market includes a wide range of products such as support pessaries, space-filling pessaries, high-profile devices, and other clinically diverse products that aid in correcting anatomical defects, restoring normal function, and minimizing related symptoms. Pessaries are cost-effective and non-surgical intervention with minimally invasive approach, often prescribed as first-line treatment for pelvic organ prolapse and urinary incontinence. The Global vaginal pessary market is estimated to be valued at US$ 411.68 Mn in 2024 and is expected to exhibit a CAGR of 8.3% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the vaginal pessary market are Arakawa Chemical Industries, Eastman Chemical Company, Exxon Mobil Corporation, Ltd., Kolon Industries, Inc., Lesco Chemical Limited, Zeon Corporation, Seacon Corporation, Neville Chemical Company, Total Cray Valley, and Anglxxon Chemical Co., Ltd. The major players are focusing on various business strategies such as new product launches, mergers and acquisitions to expand their product portfolio and strengthen their market position. Growing prevalence of POP and stress urinary incontinence due to changing lifestyle and high rate of chronic obesity are increasing the demand for vaginal pessaries globally. The manufacturers are expanding their geographical presence and production capacity to meet the rising demand from emerging markets in Asia Pacific region.

Market Drivers

The vaginal pessary market is driven by increasing prevalence of pelvic organ prolapse owing to various factors such as aging women population, obesity, childbirth injuries. Pelvic organ prolapse is a condition in women which occurs when any of the pelvic organs such as the uterus, bladder, rectum, or intestines drop down from their normal position due to weakness or damage in the muscles and tissues that hold them in place. Around 50% of women who have had children and gone through natural childbirth will develop some form of pelvic organ prolapse by middle age. As per WHO data, in 2019 around 303 million women were affected with pelvic organ prolapse globally. Vaginal pessaries provide effective non-surgical treatment option with advantages of low cost and minimal side effects.

Current Geopolitical Situation and its Impact on the Growth of Vaginal Pessary Market

The Vaginal Pessary Market Demand is witnessing varied growth trends across different geographical regions due to the evolving geopolitical environment. Growing political instability and regional conflicts in several countries are negatively impacting the women's healthcare sector. Restrictive policies and socio-cultural barriers in conflict-ridden areas are limiting access to essential medical devices like vaginal pessaries. This is hampering the growth potential of the market. Moreover, economic sanctions and supply chain disruptions arising from geopolitical tensions are disrupting production and distribution channels of key market players. Fluctuating raw material prices and operational challenges faced by manufacturers due to border issues are further inhibiting market expansion. However, governments and NGOs in developed nations are undertaking initiatives to enhance reproductive healthcare in underdeveloped regions. Expanding awareness programs and favourable reimbursement scenarios are expected to boost adoption in the long run. The market is also expected to benefit from steady demand for clinical trials of new formulations and innovative product variants across different geographical territories in the coming years.

Concentration of Vaginal Pessary Market based on Value across Geographical Regions

When analyzed based on value, the vaginal pessary markets of North America and Western Europe currently contribute to over half of the global market revenue. This is attributed to the high concentration of leading players, widespread clinical adoption, growing geriatric population susceptible to pelvic organ prolapse, and favourable reimbursement environment in these regions. Other major value generating markets include countries across East Asia, South Asia, and Latin America with increasing awareness and focus on women's health issues.

Fastest Growing Regional Market for Vaginal Pessary

The vaginal pessary market in Central and Eastern Europe is expected to witness the fastest value growth during the forecast period, expanding at a CAGR of over 10%. This can be accredited to rapid improvements in healthcare accessibility in nations like Russia, Poland and Hungary. Rising incidence of post-partum pelvic floor disorders along with initiatives towards rural healthcare upliftment are boosting market sales. Additionally, growing medical tourism industry is augmenting the demand for affordable treatment options like pessary devices in the region.

Get more insights on : Vaginal Pessary Market